Five years ago: our first bell ringing. 🔔 Today: We’re back at @NYSE, and we’re just getting started. 🚀

Midlife doesn't mean the end of your sex life. It might just look different. Hormonal shifts, stress, and changing priorities can all impact intimacy—but that doesn't mean desire disappears. Here's what women in midlife actually want you to know. bit.ly/450aQ03

Midlife isn't the end of your sex life—it may be the start of a new chapter. New insights from Hers challenge the myth that desire disappears with age. Hormonal changes can impact intimacy, but support is available. Read more: bit.ly/4wxshRu

Not all telehealth platforms are created equal. How can consumers tell the difference between a platform built for their health and one built for a quick sale? Our latest article outlines 5 signs of safe, high-quality telehealth platforms—from access to clinical evaluations to ongoing provider support. Learn more: bit.ly/4wajrc6

therapy is great (we love it) but watching the summer house reunion with your friends is also healing

A generation of women was denied menopause care because of Black Box warning misinformation. We appreciate the leadership from the FDA in removing that warning and ensuring women have access to the care they need. As demand increases, Hers has built a dependable supply of estrogen patches to make sure no one else gets left behind: bit.ly/4egK2ON

Customer access should move at the same speed as innovation. When the healthcare industry works together to reach individuals, it does. Since last week, thousands of people have signed up for our Wegovy® waitlist. Starting today, eligible Hims & Hers customers can start their journeys with @novonordisk’s FDA-approved Wegovy® Pill & Wegovy® Pen and partner with their provider on a comprehensive weight loss program designed to help them achieve their goals. We take our role as the largest global consumer health platform seriously, and I can’t wait to keep finding ways to make sure everyone can access the tools they need to feel great. Read more below from Dr. Craig, our Head of Weight Loss, on what’s available today. (And if you’re starting your Wegovy journey with us today, tag me and tell me how it’s going!) More details, including important info, here: news.hims.com/newsroom/wegov…

A new era of weight management is coming to Hims & Hers. Soon: access to FDA-approved GLP-1 treatments — including Wegovy® pills and injections. Join our exclusive pre-launch waitlist today: bit.ly/4shiU6p 𝘞𝘦𝘨𝘰𝘷𝘺® 𝘪𝘴 𝘢 𝘳𝘦𝘨𝘪𝘴𝘵𝘦𝘳𝘦𝘥 𝘵𝘳𝘢𝘥𝘦𝘮𝘢𝘳𝘬 𝘰𝘧 𝘕𝘰𝘷𝘰 𝘕𝘰𝘳𝘥𝘪𝘴𝘬 𝘈/𝘚.

Excited to introduce Hims & Hers Benefits - connecting subscribers with products that support whole body health. To kick off, we’re partnering with @Prenuvo @Eightsleep to offer whole body MRI scans and adaptive bed systems. And this is just the start! news.hims.com/newsroom/with-…

Now live: Q4/FY’25 Earnings. @AndrewDudum is reflecting on the last year and what comes next on our Newsroom: news.hims.com/newsroom/how-m… Important info here: investors.hims.com/files/doc… news.hims.com/disclaimers/ca…

Personalized weight management treatment plans are now available across the pond! Starting today, if suitable, customers in the United Kingdom have access to a comprehensive weight loss programme through Hims & Hers. This includes the launch of @wearehers in the UK with convenient, personalized support for customers’ weight loss journeys. 🇬🇧🇬🇧🇬🇧 news.hims.com/newsroom/hims-…

Hims & Hers acquires Livewell in Canada in anticipation of generic Ozempic theglobeandmail.com/business…

O @Canada! Hims & Hers has officially arrived in the Great White North. 🇨🇦 Starting today, Hims & Hers is serving Canada for the first time. And, to best support these customers, we’ve welcomed new local leadership focused on delivering access to the personalized, affordable care that Canadians need. More below ⬇️ news.hims.com/newsroom/hims-…

For too long, your health data hasn’t been yours.
It’s been buried, restricted, out of reach.
It’s time to take it back. Learn more: bit.ly/4nU3pOP

Introducing Labs by Hims & Hers. A new experience that gives you a more proactive role in maintaining your health. From testing to treatment to feeling great, Labs is accessible, actionable, and custom-built around you. A Base plan and Advanced plan offer two options for over 120 biomarker tests across 10 key categories with a personal Action Plan. CEO, Andrew Dudum is joined by Chief Product Officer, Dheerja Kaur and Chief Medical Officer, Dr. Patrick Carroll to show how Hims & Hers is leading a new era of personal, proactive healthcare. Learn more at bit.ly/4nU3pOP

Join us live now for what's new at Hims & Hers: hims.com/events

You track your steps. Your water intake. Your sleep. Your calories. But how is it all connected? What’s the whole picture? Something new is coming November 13th. Learn more at hims.com/events

Join me live next Thursday to see what’s next. hims.com/events

Q3’25 Earnings are live! Read more from @AndrewDudum on why he’s so excited about this moment: news.hims.com/newsroom/how-w… Important info here: news.hims.com/disclaimers/ca…

Last Wednesday at Quarters in New York City, to celebrate the launch of a new offering through Hers for women experiencing perimenopause and menopause, our Chief Medical Officer Dr. Jessica Shepherd hosted an intimate gathering with entrepreneur, actress, and founder of YSE Beauty, Molly Sims. This event was a necessary moment for women to come together and speak their truth. As Molly shared her personal journey, she captured the spirit of our mission at Hers: “Traditionally, it’s been hard for people to relate to or understand what women go through. But it doesn’t have to be that way. Now more than ever, we have a voice and can name our experiences. The more we talk openly about perimenopause and menopause, the more society will normalize and embrace these conversations.” Watch some of the highlights of the conversation and the night now: piped.video/zIY0wA7sn0s 𝘛𝘩𝘪𝘴 𝘱𝘰𝘴𝘵 𝘧𝘦𝘢𝘵𝘶𝘳𝘦𝘴 𝘔𝘰𝘭𝘭𝘺 𝘚𝘪𝘮𝘴, 𝘸𝘩𝘰 𝘸𝘢𝘴 𝘤𝘰𝘮𝘱𝘦𝘯𝘴𝘢𝘵𝘦𝘥 𝘧𝘰𝘳 𝘩𝘦𝘳 𝘱𝘢𝘳𝘵𝘪𝘤𝘪𝘱𝘢𝘵𝘪𝘰𝘯.